Suppression of interferon signaling via small-molecule modulation of TFAM.
Saved in:
| Title: | Suppression of interferon signaling via small-molecule modulation of TFAM. |
|---|---|
| Authors: | Sideris D; Astellas Pharmaceuticals Inc, Oncology Research, Cancer Biology, Cambridge, United States., Lee H; Astellas Pharmaceuticals Inc, Oncology Research, Cancer Biology, Cambridge, United States., Olson L; Astellas Pharmaceuticals Inc, Oncology Research, Cancer Biology, Cambridge, United States., Nallaparaju K; Astellas Pharmaceuticals Inc, Oncology Research, Cancer Biology, Cambridge, United States., Okuyama K; Astellas Pharmaceuticals Inc, Oncology Medicinal Chemistry, Cambridge, United States., Ciavarri J; Astellas Pharmaceuticals Inc, Oncology Medicinal Chemistry, Cambridge, United States., Lafyatis R; Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, United States., Larsen M; Aging Institute, University of Pittsburgh/UPMC, Pittsburgh, United States., Lin B; Aging Institute, University of Pittsburgh/UPMC, Pittsburgh, United States., Alfaras I; Aging Institute, University of Pittsburgh/UPMC, Pittsburgh, United States., Kennerdell J; Aging Institute, University of Pittsburgh/UPMC, Pittsburgh, United States., Finkel T; Aging Institute, University of Pittsburgh/UPMC, Pittsburgh, United States.; Department of Medicine, Division of Cardiology, University of Pittsburgh, Pittsburgh, United States.; Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, United States., Liu Y; Aging Institute, University of Pittsburgh/UPMC, Pittsburgh, United States.; Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, United States.; Generian Pharmaceuticals, Pittsburgh, United States., Chen B; Aging Institute, University of Pittsburgh/UPMC, Pittsburgh, United States.; Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, United States.; Generian Pharmaceuticals, Pittsburgh, United States.; Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, United States., Lyu L; Astellas Pharmaceuticals Inc, Oncology Research, Cancer Biology, Cambridge, United States. |
| Source: | ELife [Elife] 2026 Feb 06; Vol. 14. Date of Electronic Publication: 2026 Feb 06. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41649246 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Suppression of interferon signaling via small-molecule modulation of TFAM. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Sideris+D%22">Sideris D</searchLink>; Astellas Pharmaceuticals Inc, Oncology Research, Cancer Biology, Cambridge, United States.<br /><searchLink fieldCode="AU" term="%22Lee+H%22">Lee H</searchLink>; Astellas Pharmaceuticals Inc, Oncology Research, Cancer Biology, Cambridge, United States.<br /><searchLink fieldCode="AU" term="%22Olson+L%22">Olson L</searchLink>; Astellas Pharmaceuticals Inc, Oncology Research, Cancer Biology, Cambridge, United States.<br /><searchLink fieldCode="AU" term="%22Nallaparaju+K%22">Nallaparaju K</searchLink>; Astellas Pharmaceuticals Inc, Oncology Research, Cancer Biology, Cambridge, United States.<br /><searchLink fieldCode="AU" term="%22Okuyama+K%22">Okuyama K</searchLink>; Astellas Pharmaceuticals Inc, Oncology Medicinal Chemistry, Cambridge, United States.<br /><searchLink fieldCode="AU" term="%22Ciavarri+J%22">Ciavarri J</searchLink>; Astellas Pharmaceuticals Inc, Oncology Medicinal Chemistry, Cambridge, United States.<br /><searchLink fieldCode="AU" term="%22Lafyatis+R%22">Lafyatis R</searchLink>; Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, United States.<br /><searchLink fieldCode="AU" term="%22Larsen+M%22">Larsen M</searchLink>; Aging Institute, University of Pittsburgh/UPMC, Pittsburgh, United States.<br /><searchLink fieldCode="AU" term="%22Lin+B%22">Lin B</searchLink>; Aging Institute, University of Pittsburgh/UPMC, Pittsburgh, United States.<br /><searchLink fieldCode="AU" term="%22Alfaras+I%22">Alfaras I</searchLink>; Aging Institute, University of Pittsburgh/UPMC, Pittsburgh, United States.<br /><searchLink fieldCode="AU" term="%22Kennerdell+J%22">Kennerdell J</searchLink>; Aging Institute, University of Pittsburgh/UPMC, Pittsburgh, United States.<br /><searchLink fieldCode="AU" term="%22Finkel+T%22">Finkel T</searchLink>; Aging Institute, University of Pittsburgh/UPMC, Pittsburgh, United States.; Department of Medicine, Division of Cardiology, University of Pittsburgh, Pittsburgh, United States.; Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, United States.<br /><searchLink fieldCode="AU" term="%22Liu+Y%22">Liu Y</searchLink>; Aging Institute, University of Pittsburgh/UPMC, Pittsburgh, United States.; Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, United States.; Generian Pharmaceuticals, Pittsburgh, United States.<br /><searchLink fieldCode="AU" term="%22Chen+B%22">Chen B</searchLink>; Aging Institute, University of Pittsburgh/UPMC, Pittsburgh, United States.; Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, United States.; Generian Pharmaceuticals, Pittsburgh, United States.; Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, United States.<br /><searchLink fieldCode="AU" term="%22Lyu+L%22">Lyu L</searchLink>; Astellas Pharmaceuticals Inc, Oncology Research, Cancer Biology, Cambridge, United States. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101579614%22">ELife</searchLink> [Elife] 2026 Feb 06; Vol. 14. <i>Date of Electronic Publication: </i>2026 Feb 06. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22eLife+Sciences+Publications%2C+Ltd%22">eLife Sciences Publications, Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101579614 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2050-084X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222050084X%22">2050084X </searchLink><i>NLM ISO Abbreviation: </i>Elife <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41649246 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.7554/eLife.108742 Languages: – Code: eng Text: English Titles: – TitleFull: Suppression of interferon signaling via small-molecule modulation of TFAM. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Sideris D – PersonEntity: Name: NameFull: Lee H – PersonEntity: Name: NameFull: Olson L – PersonEntity: Name: NameFull: Nallaparaju K – PersonEntity: Name: NameFull: Okuyama K – PersonEntity: Name: NameFull: Ciavarri J – PersonEntity: Name: NameFull: Lafyatis R – PersonEntity: Name: NameFull: Larsen M – PersonEntity: Name: NameFull: Lin B – PersonEntity: Name: NameFull: Alfaras I – PersonEntity: Name: NameFull: Kennerdell J – PersonEntity: Name: NameFull: Finkel T – PersonEntity: Name: NameFull: Liu Y – PersonEntity: Name: NameFull: Chen B – PersonEntity: Name: NameFull: Lyu L IsPartOfRelationships: – BibEntity: Dates: – D: 06 M: 02 Text: 2026 Feb 06 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2050-084X Numbering: – Type: volume Value: 14 Titles: – TitleFull: ELife Type: main |
| ResultId | 1 |